Cargando…
Pharmacokinetics and dialytic clearance of apixaban during in vitro continuous renal replacement therapy
BACKGROUND: To evaluate the transmembrane clearance (CL(TM)) of apixaban during modeled in vitro continuous renal replacement therapy (CRRT), assess protein binding and circuit adsorption, and provide initial dosing recommendations. METHODS: Apixaban was added to the CRRT circuit and serial pre-filt...
Autores principales: | Andrews, Lauren, Benken, Scott, Tan, Xing, Wenzler, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847018/ https://www.ncbi.nlm.nih.gov/pubmed/33516188 http://dx.doi.org/10.1186/s12882-021-02248-7 |
Ejemplares similares
-
Pharmacokinetics, Pharmacodynamics, and Dose Optimization of Cefiderocol during Continuous Renal Replacement Therapy
por: Wenzler, Eric, et al.
Publicado: (2021) -
Correction to: Pharmacokinetics, Pharmacodynamics, and Dose Optimization of Cefiderocol during Continuous Renal Replacement Therapy
por: Wenzler, Eric, et al.
Publicado: (2022) -
Safety and Efficacy of Apixaban For Therapeutic Anticoagulation in Critically Ill ICU Patients with Severe COVID-19 Respiratory Disease
por: Wenzler, Eric, et al.
Publicado: (2020) -
Intra-dialytic hypotension following the transition from continuous to intermittent renal replacement therapy
por: Beaubien-Souligny, William, et al.
Publicado: (2021) -
The contribution of apixaban renal clearance to total clearance
por: Frost, Charles, et al.
Publicado: (2015)